9 Meters Biopharma Long Term Debt

9 Meters Biopharma (NMTR) currently reports a long-term debt of $35K as of March 2023. That compares with $98K in the prior-year period — down 64.7% year over year. Use the charts on this page to explore 9 Meters Biopharma's long-term debt history and peer comparisons.

9 Meters Biopharma's long-term debt decreased from $98K to $35K — a 64.7% year-over-year decrease (period ending March 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

9 Meters Biopharma reported $35K in long-term debt as of March 2023. That compares with $98K in the prior-year period — down 64.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $35K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for 9 Meters Biopharma, and consider following NMTR for alerts when major investors trade the stock.

9 Meters Biopharma is classified in the Technology sector. On long-term debt, it currently shows $35K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Technology are usually more informative than comparing NMTR with unrelated industries.